Form 4: Bluebird Bio CEO Andrew Obenshain Acquires and Disposes of Shares to Cover Tax Obligations
SEC Form 4
Andrew Obenshain, CEO of Bluebird Bio, reports acquisition of 130,000 shares of common stock and disposition of 34,780 shares to cover tax obligations related to vesting restricted stock units.
Summary
- On September 30, 2024, Andrew Obenshain, the President and CEO of bluebird bio, Inc., acquired 130,000 shares of common stock.
- The acquisition was related to restricted stock units vesting over a four-year period.
- On the same day, Obenshain disposed of 34,780 shares of common stock at an average price of $0.5253 to cover tax withholding obligations.
- Following these transactions, Obenshain beneficially owns 375,218 shares of bluebird bio, Inc.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 09/23/2024 | Date of Power of Attorney execution. |
| 09/30/2024 | Date of stock acquisition and disposition. |
| 03/01/2025 | First vesting date of restricted stock units. |
| 03/01/2026 | Second vesting date of restricted stock units. |
| 03/01/2027 | Third vesting date of restricted stock units. |
| 03/01/2028 | Final vesting date of restricted stock units. |
| 10/02/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.